Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
View through CrossRef
Background Sepsis-associated cholestasis (SAC) is an intrahepatic cholestasis caused by inflammatory cytokines. Patients with this condition have poor prognoses. Antibiotics are the mainstay of therapy, however, other adjuvant therapies, such as ursodeoxycholic acid (UDCA), have not been well established.Objective To assess the effect ofUDCA for treatment ofneonatal sepsis-associated cholestasis.Methods We performed a randomized, double-blind, controlled trial in 3 7 neonates who were diagnosed with sepsis-associated cholestasis in the Neonatal Care Unit of Cipto Mangunkusumo Hospital. Subjects were divided into two groups, with 19 neonates randomly allocated to the intervention group (received UDCA at 30 tngikg/day divided into 3 doses for 7 days) and 18 neonates to the control group (received placebo) . After 7 days of treatment, we evaluated the subjects' liver function parameters and performed asurvival analysis.Results Liver function parameter improvements at day 7 were not significantly different between the UDCA group and the control group, including for mean decrease of total bilirubin (TB) levels [2.2 (SD 2.9) mg/dL vs 1.7 (SD 4.6) mg/dL; P=0.080), mean decrease of direct bilirubin (DB) levels [1.1 (SD 2.3) mg/dL vs 0.6 (SD 3.6) mg/dL; P=0.080), median indirect bilirubin (lB) levels [0.4 (range 0.1- 5.6) mg/dL vs 0.9 (range 0.1-4.1) mg/dL; P=0.358) , mean decrease of alanine aminotransferase (ALT) levels [0.5 (-80.0 -21.0) U/L vs -2.0 (ranged -167 .0 - 85.0) U/L; P= 0.730), median aspartate aminotransferase (AST) levels [ 43 .0 (range 14.0-297 .0) U/L vs 150.0 (range 24.0-840.0) U/L; P=0.081), and median gamma-glutamyl transpeptidase (GGf) levels [125.0 (48.0-481.0) U/L vs 235.0 (56.0-456.0) U/L; P=0.108)). Five neonates in control group died compared to two in the UDCA group (P=0.232). In addition, UDCA did not significantly lengthen the survival time (hazard ratio/HR 3.62; 95%CI 0.69 to 18.77) .Conclusion Ursodeoxycholic acid tends to improve total bilirubin, direct bilirubin, and AST levels in sepsis associated cholestasis .
Paediatrica Indonesiana - Indonesian Pediatric Society
Title: Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
Description:
Background Sepsis-associated cholestasis (SAC) is an intrahepatic cholestasis caused by inflammatory cytokines.
Patients with this condition have poor prognoses.
Antibiotics are the mainstay of therapy, however, other adjuvant therapies, such as ursodeoxycholic acid (UDCA), have not been well established.
Objective To assess the effect ofUDCA for treatment ofneonatal sepsis-associated cholestasis.
Methods We performed a randomized, double-blind, controlled trial in 3 7 neonates who were diagnosed with sepsis-associated cholestasis in the Neonatal Care Unit of Cipto Mangunkusumo Hospital.
Subjects were divided into two groups, with 19 neonates randomly allocated to the intervention group (received UDCA at 30 tngikg/day divided into 3 doses for 7 days) and 18 neonates to the control group (received placebo) .
After 7 days of treatment, we evaluated the subjects' liver function parameters and performed asurvival analysis.
Results Liver function parameter improvements at day 7 were not significantly different between the UDCA group and the control group, including for mean decrease of total bilirubin (TB) levels [2.
2 (SD 2.
9) mg/dL vs 1.
7 (SD 4.
6) mg/dL; P=0.
080), mean decrease of direct bilirubin (DB) levels [1.
1 (SD 2.
3) mg/dL vs 0.
6 (SD 3.
6) mg/dL; P=0.
080), median indirect bilirubin (lB) levels [0.
4 (range 0.
1- 5.
6) mg/dL vs 0.
9 (range 0.
1-4.
1) mg/dL; P=0.
358) , mean decrease of alanine aminotransferase (ALT) levels [0.
5 (-80.
0 -21.
0) U/L vs -2.
0 (ranged -167 .
0 - 85.
0) U/L; P= 0.
730), median aspartate aminotransferase (AST) levels [ 43 .
0 (range 14.
0-297 .
0) U/L vs 150.
0 (range 24.
0-840.
0) U/L; P=0.
081), and median gamma-glutamyl transpeptidase (GGf) levels [125.
0 (48.
0-481.
0) U/L vs 235.
0 (56.
0-456.
0) U/L; P=0.
108)).
Five neonates in control group died compared to two in the UDCA group (P=0.
232).
In addition, UDCA did not significantly lengthen the survival time (hazard ratio/HR 3.
62; 95%CI 0.
69 to 18.
77) .
Conclusion Ursodeoxycholic acid tends to improve total bilirubin, direct bilirubin, and AST levels in sepsis associated cholestasis .
Related Results
Sepsis-Related Mortality Rates and Trends Based on Site of Infection
Sepsis-Related Mortality Rates and Trends Based on Site of Infection
OBJECTIVES:
Sepsis is defined as life-threatening organ dysfunction triggered by an underlying infection. A recent study noted that the overall sepsis-related mortality...
To Determine The Association Of Serum Neopterin Levels In Sepsis
To Determine The Association Of Serum Neopterin Levels In Sepsis
Abstract
ABSTRACT
Background: Sepsis is a leading cause of death worldwide. Sepsis results in state of multiorgan dysfunction in the body. Early identification and appropri...
Neonatal Sepsis and Associated Factor among Neonate Admitted in Nicu at Hiwot Fana Specialized University Hospital Harar Town, Eastern, Ethiopia 2020
Neonatal Sepsis and Associated Factor among Neonate Admitted in Nicu at Hiwot Fana Specialized University Hospital Harar Town, Eastern, Ethiopia 2020
Background:Neonatal sepsis is a condition defined as a clinical syndrome characterized by signs and symptoms of infection in an infant 28 days of life or younger. Neonatal sepsis i...
Patterns of morbidity and mortality among neonates admitted in Mirwais regional hospital, Kandahar, Afghanistan
Patterns of morbidity and mortality among neonates admitted in Mirwais regional hospital, Kandahar, Afghanistan
ABSTRUCTBackgroundNeonatal health is a critical global concern that reflects the national and global progress and challenges of health systems. Neonatal morbidity and mortality are...
Time to death and its predictors among neonates admitted with sepsis in neonatal intensive care unit at comprehensive specialized hospitals in Northeast Ethiopia
Time to death and its predictors among neonates admitted with sepsis in neonatal intensive care unit at comprehensive specialized hospitals in Northeast Ethiopia
BackgroundIn impoverished nations like Ethiopia, neonatal sepsis contributes significantly to neonatal mortality. Despite variations in the specific timing of death and predictors ...
Clinicopathological and bacteriological profile of neonatal sepsis: a tertiary centre experience from Bangladesh
Clinicopathological and bacteriological profile of neonatal sepsis: a tertiary centre experience from Bangladesh
Introduction: Neonatal sepsis is a primary cause of newborn hospitalization, morbidity, and mortality. Common newborn sepsis symptoms are widely documented. Bacterial and non-bacte...
Predictors of mortality in neonatal sepsis in a resource-limited setting
Predictors of mortality in neonatal sepsis in a resource-limited setting
Introduction: Sepsis remains a major cause of death in neonatal period. Although significant advances in diagnosis, therapeutic and prevention strategies have been noted, sepsis re...
Clinical outcomes of early neonatal sepsis and associated factors in Debre- Tabor comprehensive specialized hospital in Amhara region, Ethiopia
Clinical outcomes of early neonatal sepsis and associated factors in Debre- Tabor comprehensive specialized hospital in Amhara region, Ethiopia
Abstract
Background: Globally, early neonatal sepsis is one of the foremost reasons for exaggerated death and illness of neonates. It is also one of the most common causes ...